Men's Health News RSS Feed - Men's Health News

New study shows safe levels of exercise differ for men and women with Atrial Firbrillation

New study shows safe levels of exercise differ for men and women with Atrial Firbrillation

Data from nearly 380,000 patients presented at Heart Rhythm 2015 reveals that moderate exercise is beneficial, yet vigorous exercise can increase the risk of AF for men [More]
Results from four major studies on cancer treatments to be presented at ASCO Annual Meeting

Results from four major studies on cancer treatments to be presented at ASCO Annual Meeting

The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma. [More]
Regular exercise reduces mortality risk in elderly men

Regular exercise reduces mortality risk in elderly men

The results of a long-term trial show that regular exercise reduces the all-cause death rate in elderly men by 40%... [More]
Rises in unemployment linked to significant increases in prostate cancer mortality

Rises in unemployment linked to significant increases in prostate cancer mortality

The knock-on effects of the economic downturn have been explored in economy and psychology. Now researchers are examining the effects of unemployment on an even darker subject - cancer mortality. [More]

Immunotherapy for kidney cancer - Phase 3 update from Argos Therapeutics at ASCO

Argos is developing AGS-003, which is a fully personalized immunotherapy designed to induce a durable memory T-cell response specific to each patient’s cancer... [More]
Men with asthma less likely to develop lethal prostate cancer

Men with asthma less likely to develop lethal prostate cancer

Scientists found that men with a history of asthma were 29 percent less likely to have been diagnosed with prostate cancer that spread or to have died of their prostate cancer... [More]
Hand-grip strength could be used as a predictor of stroke and heart attack

Hand-grip strength could be used as a predictor of stroke and heart attack

The authors of the study say grip strength was a stronger predictor of death than systolic blood pressure and that a grip test may provide a simple and cost-effective way of identifying people at high risk of heart attack or stroke... [More]
Study provides comprehensive analysis of economic burden in cancer survivors

Study provides comprehensive analysis of economic burden in cancer survivors

A new study finds the economic burden of cancer extends beyond diagnosis and treatment, and concludes that cancer survivors face thousands of dollars of excess medical expenses every year as well as excess employment disability and loss of production at work. [More]
Prostate cancer patients who receive androgen deprivation therapy may experience cognitive problems

Prostate cancer patients who receive androgen deprivation therapy may experience cognitive problems

Cognitive impairment can occur in cancer patients who are treated with a variety of therapies, including radiation therapy, hormone therapy, and chemotherapy. After chemotherapy treatment it is commonly called "chemo brain." Signs of cognitive impairment include forgetfulness, inability to concentrate, problems recalling information, trouble multi-tasking and becoming slower at processing information. [More]

WHO Press Release: World Health Statistics reports on global health goals for 194 countries

Progress in child survival worldwide is one of the greatest success stories of international development. Since 1990, child deaths have almost halved – falling from an estimated 90 deaths per 1000 live births to 46 deaths per 1000 live births in 2013... [More]
Managing cancer at work: Johns Hopkins launches new service for all employees

Managing cancer at work: Johns Hopkins launches new service for all employees

Johns Hopkins Medicine has created and launched Managing Cancer at Work, a new and novel health benefit program offered free of charge for its more than 42,000 combined full-time equivalent employees. [More]
Research finds link between oestrogen levels and male breast cancer

Research finds link between oestrogen levels and male breast cancer

Men with naturally high levels of the female hormone oestrogen may have a greater risk of developing breast cancer, according to research by an international collaboration including Cancer Research UK published today in the Journal of Clinical Oncology. [More]
1 in 10 patients harmed while in hospital - Addressing the big problem?

1 in 10 patients harmed while in hospital - Addressing the big problem?

It is now widely accepted that 1 in 10 patients admitted to hospital will be unintentionally harmed in some way. This harm can be caused by a range of errors or adverse events... [More]
World renowned surgeon evaluates parallels between Prostate cancer, Breast cancer

World renowned surgeon evaluates parallels between Prostate cancer, Breast cancer

World renowned robotic prostate cancer surgeon, Dr. David Samadi, evaluates the parallels between Prostate cancer and Breast cancer. Prostate cancer is just as common in men as breast cancer is in women with over 233,000 cases diagnosed each year. [More]
Experimental gene therapy holds promise against metastatic prostate cancer

Experimental gene therapy holds promise against metastatic prostate cancer

Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies for these patients, researchers at VCU Massey Cancer Center and the VCU Institute of Molecular Medicine have developed a unique approach that uses microscopic gas bubbles to deliver directly to the cancer a viral gene therapy in combination with an experimental drug that targets a specific gene driving the cancer's growth. [More]
Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

Raising lupus awareness: an interview with Professor Ramsey-Goldman, MD

Lupus is a chronic, autoimmune disease, with many different symptoms so it is hard to diagnose. It affects each person differently and it has an unpredictable disease course with flare ups and quiet time. Some patients describe lupus as if they are riding a roller coaster with blinders on because they cannot always tell when they will feel well or sick... [More]
The future of cancer treatment set to be transformed through the opening of new Cancer Institute

The future of cancer treatment set to be transformed through the opening of new Cancer Institute

NHS patients will soon benefit from the opening of a new cancer centre specialising in the use of diagnostics for targeted cancer medicines used to treat some of the UK’s most common cancers... [More]

A pioneering facial recognition cane for the blind

The ‘XploR’ mobility cane, being developed by ICT students Steve Adigbo, Waheed Rafiq and Richard Howlett, uses smartphone technology to recognise familiar faces from up to 10m away. The cane also features GPS functionality to aid navigation... [More]
Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy. [More]
Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Cholesterol-lowering statin drugs could delay prostate cancer growth in patients receiving ADT

Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows. [More]
Advertisement
Advertisement